- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/72 - QuinazolinesQuinazolines hydrogénées
Détention brevets de la classe C07D 239/72
Brevets de cette classe: 259
Historique des publications depuis 10 ans
|
7
|
15
|
6
|
9
|
8
|
10
|
13
|
12
|
12
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4645 |
9 |
| Merck Patent GmbH | 5814 |
8 |
| Janssen Pharmaceutica N.V. | 3376 |
6 |
| Gilead Sciences, Inc. | 2041 |
6 |
| Bristol-myers Squibb Company | 4872 |
5 |
| Merck Sharp & Dohme Corp. | 2191 |
4 |
| Nerviano Medical Sciences S.r.l. | 257 |
4 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3174 |
4 |
| Merck Sharp & Dohme LLC | 3748 |
4 |
| Emory University | 1625 |
3 |
| Exelixis, Inc. | 400 |
3 |
| Hutchison MediPharma Enterprises Limited | 14 |
3 |
| Myriad Pharmaceuticals, Inc. | 10 |
3 |
| Reata Pharmaceuticals, Inc. | 123 |
3 |
| Sichuan Huiyu Pharmaceutical Co., Ltd. | 30 |
3 |
| Wuhan LL Science and Technology Development Co., Ltd | 71 |
3 |
| Hutchmed Limited | 29 |
3 |
| Sichuan Huiyu Seacross Pharmaceutical Technology Co., Ltd. | 22 |
3 |
| Genentech, Inc. | 3979 |
2 |
| President and Fellows of Harvard College | 5993 |
2 |
| Autres propriétaires | 178 |